iShares U.S. Medical Devices ETF (IHI)
| Assets | $4.16B |
| Expense Ratio | 0.38% |
| PE Ratio | 27.85 |
| Shares Out | 68.10M |
| Dividend (ttm) | $0.26 |
| Dividend Yield | 0.42% |
| Ex-Dividend Date | Sep 16, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 11.77% |
| Volume | 1,977,236 |
| Open | 60.30 |
| Previous Close | 60.60 |
| Day's Range | 59.86 - 60.74 |
| 52-Week Low | 52.91 |
| 52-Week High | 65.18 |
| Beta | 0.94 |
| Holdings | 54 |
| Inception Date | May 1, 2006 |
About IHI
Fund Home PageThe iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select / Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is issued by BlackRock.
Top 10 Holdings
76.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Abbott Laboratories | ABT | 17.79% |
| Intuitive Surgical, Inc. | ISRG | 16.14% |
| Boston Scientific Corporation | BSX | 12.03% |
| IDEXX Laboratories, Inc. | IDXX | 5.10% |
| Edwards Lifesciences Corporation | EW | 4.78% |
| Medtronic plc | MDT | 4.42% |
| Becton, Dickinson and Company | BDX | 4.23% |
| Stryker Corporation | SYK | 4.22% |
| GE HealthCare Technologies Inc. | GEHC | 4.13% |
| ResMed Inc. | RMD | 4.10% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 16, 2025 | $0.06088 | Sep 19, 2025 |
| Jun 16, 2025 | $0.05535 | Jun 20, 2025 |
| Mar 18, 2025 | $0.03299 | Mar 21, 2025 |
| Dec 17, 2024 | $0.10733 | Dec 20, 2024 |
| Sep 25, 2024 | $0.07966 | Sep 30, 2024 |
| Jun 11, 2024 | $0.05294 | Jun 17, 2024 |
Performance
IHI had a total return of 2.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.22%.
News
IHI: Medical Device ETF Continues To Lag, No Momentum In Sight
iShares U.S. Medical Devices ETF continues to underperform the S&P 500, hitting multi-year relative lows since 2012. IHI's valuation remains elevated with a P/E above 25x and a high PEG ratio, while e...
IHI: Strong Industry Trends, But Valuation Too High
iShares U.S. Medical Devices ETF offers targeted exposure to U.S. medical device leaders, benefiting from demographic shifts and innovation, but is highly concentrated in top holdings. Current valuati...
IHI Raw Analysis: No Active Return In Sight
IHI's strategy provides exposure to the medical devices industry via a representative index sampling method. Here, I illustrate the fund has added zero risk-adjusted active return above the SPY these ...
Healthcare Stocks Avoid Tariff Damage. There Are Other Problems.
The threat of cuts to Medicaid, plus uncertainty over what the confirmation of Robert F. Kennedy Jr. to lead the U.S. health bureaucracy will mean for the sector, have weighed on the stocks.
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
Health care bounce is starting to brew, says Strategas' Chris Verrone
Chris Verrone, Strategas head of technical and macro research, joins 'Closing Bell' to discuss the bullish technical signs he's seeing.
IHI: Multiples Have Climbed Despite Stubborn Rates
iShares U.S. Medical Devices ETF has stocks that are still dealing with tough comps from COVID-19, though those pressures are vanishing now. IHI multiples remain really high, which is a bit of a conce...
Final Trades: CME Group, Chubb, Berkshire Hathaway and the IHI
The Investment Committee give you their top stocks to watch for the second half.
IHI: A Pricey P/E But Bullish Chart Setup
Health Care sector at 52-week highs, led by Eli Lilly. Hold rating on iShares U.S. Medical Devices ETF (IHI) due to high valuation and secular headwinds. IHI has strong chart setup but high valuation,...
IHI: Despite Steady Returns At Current Prices, ETF Is Fairly Valued
iShares U.S. Medical Devices ETF has underperformed in recent times. The healthcare sector is considered defensive, but medical devices may still be sensitive to economic downturns. IHI's present valu...
IHI Appoints Susan Ehrlich, CEO of Zuckerberg San Francisco General, to its Board of Directors
BOSTON--(BUSINESS WIRE)-- #IHIForum--The Institute for Healthcare Improvement (IHI) has announced that Susan Ehrlich, MD, MPP, has joined its Board of Directors.
IHI Lucian Leape Institute Releases Artificial Intelligence (AI) Recommendations for Patient Safety and Health System Leaders
BOSTON & ORLANDO, Fla.--(BUSINESS WIRE)-- #IHIForum--The IHI Lucian Leape Institute (LLI) today released, “Patient Safety and Artificial Intelligence: Opportunities and Challenges for Care Delivery.”.
IHI and The DAISY Foundation™ Honor Extraordinary Nurses in Patient Safety
BOSTON--(BUSINESS WIRE)-- #daisyaward--The Institute for Healthcare Improvement (IHI) and The DAISY Foundation have announced the recipients of the 10th annual DAISY Award®.
IHI Launches First Collaborative to Accelerate System-Wide Spread of Age-Friendly Care for Older Adults
BOSTON--(BUSINESS WIRE)-- #AFHS--The Institute for Healthcare Improvement has launched an Age-Friendly System-Wide Spread Collaborative, engaging 30 health systems across the US.
IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF
iShares U.S. Medical Devices ETF has demonstrated the greatest long-term performance among peer funds and is uniquely postured for growth looking forward given its mix of top holdings. Abbott Laborato...
IHI: High Valuation But Growing Healthcare Play
Investing in medical device stocks can be a compelling option due to the growing industry, high demand, and technological advancements. The iShares U.S. Medical Devices ETF provides broad exposure to ...
IHI: Nibbling Again On Attractive Healthcare Sector Valuation
The healthcare sector has underperformed but shows signs of improvement. Non-pharma industries may offer better value in the long term.
The FDA Crash - Are Regulations Killing The Bull Case For Medical Devices And IHI?
FDA announcement of the creation of a Digital Health Advisory Committee causes a 7.2% decline in the iShares U.S. Medical Devices ETF. Digital health industry shows immense potential, driven by consum...
IHI: Too Expensive Considering Long-Term Rate Uncertainty
It appears that the performance of iShares U.S. Medical Devices ETF isn't taking into account any expectations of long-term rates in bond markets. Long-term rates have an outsized impact on stocks who...
IHI: Larger Healthcare Equipment Companies Are At An Advantage
The top 10 companies of IHI account for a large majority of 71% of its total holdings and have a slightly stronger outlook this year supported by stronger average management guidance. The top IHI comp...
IHI: Valuation Still Rich Despite The Decline In 2022
IHI invests in large-cap medical devices stocks in the United States. The fund has a long run way of growth thanks to long-term growth trends in the medical devices industry.
IHI Is Just So Expensive
Something about medical devices seems to encourage huge premiums on the multiples. Thermo Fisher and Abbott Labs are still dealing with the substantial come-down of their COVID-19 supported revenue.
IHI Forum Convenes With Call to Action for a System-Wide Approach to Health Equity
BOSTON & ORLANDO, Fla.--(BUSINESS WIRE)--Dr. Kedar Mate, President and CEO of the Institute for Healthcare Improvement (IHI), kicked-off the IHI Forum 2022 today by calling for collective action to ...
IYH And IHI ETFs: These 2 Healthcare/Medical Funds Compliment Each Other
The iShares U.S. Healthcare ETF (IYH) seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped Index composed of U.S. equities. The iShares U.S. Medical Devices ETF (IH...
What The Inflation Reduction Act Means For Drug Prices
The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs ...
IHI Can Boast Of Secular Growth, But Abbott Hinders Resilience
Thinking more about ETF options for the pandemic, one might consider something like medical devices. Medical devices often have interesting economics, namely high barriers to entry once MDs become com...
IHI: Poor Price Performance May Be Temporary
Healthcare equipment and Medical Devices sector stood out during the covid-19 pandemic crisis and delivered strong returns over the medium and long term. Stocks from healthcare equipment and Medical D...
IHI: A Standout Performer With Equally Strong Future Growth Prospects
IHI is one of the rare healthcare ETF to outperform S&P 500.
IHI: Medical Device Stocks Are Probably Overvalued
IHI recently saw significant inflows. However, while IHI is finding some recent support near all-time highs, I think the positive sentiment has some room to unwind.
iShares U.S. Medical Devices ETF: Oh My, How I Relish Outperformance
Companies in the medical device field tend to have more stable revenues, less exposure to patent expiration issues, and usually smaller in size than those found in the pharmaceutical segment. Accordin...
Final Trades: PFE, IHI, YOU & FL
The traders with their final trades of the week. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Karen Finerman, Steve Grasso and Nadine Terman.
IHI: This iShares ETF Targets The Medical Devices Market
Unlike Health Care sector ETFs, the iShares U.S. Medical Devices ETF only invests in companies that supply the medical device segment.
IHI: Bright Future Despite Recent Softness
IHI is a $7.5 billion fund that tracks the market cap-weighted Dow Jones U.S. Select Medical Equipment Index. As of June 9, the fund had 63 holdings, three of which accounted for over 35% of the NAV w...
Final Trades: Hanesbrands, Norwegian Cruise Line, Medtronic & more
The "Halftime Report" traders give their top picks to watch for the second half.
iShares U.S. Medical Devices ETF: Investors Can Expect Solid As A Rock Performance
The iShares U.S. Medical Devices ETF has delivered returns of over 14% annually since its inception in 2006. The ETF is an efficient way to gain exposure to a group of companies that manufacture and d...
iShares U.S. Medical Devices ETF - Key Themes
The prospects of IHI's major holdings look good. IHI may not be as cost efficient as XHE, but its risk-return stats, future earnings potential, and valuation are all better than the latter.
How to trade health care stocks into the 2020 U.S. presidential election
With less than a month until the election, and Democratic challenger Joe Biden opening up a wide lead, two market analysts lay out how to trade the politically sensitive health-care sector.
The iShares U.S. Medical Devices ETF: Medical Devices Look A Little Risky During A Pandemic
The iShares U.S. Medical Devices ETF is a market-cap-weighted ETF that invests in medical device companies.
Trump vs Biden: Here are the health-care stocks that could benefit from the 2020 election
Health care is again at a political crossroads heading into the U.S. presidential election. Gina Sanchez of Chantico Global and Craig Johnson of Piper Sandler discuss the potential winners and losers ...
Abbott Labs sends iShares U.S. Medical Devices ETF higher
CNBC's Kayla Tausche reports on why iShares Medical Devices ETF is heading upwards.